Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Operating Expenses | 14,618 | 12,392 | 11,355 | 8,540 | 10,170 |
| Operating Income | -14,618 | -12,392 | -11,355 | -8,540 | -10,170 |
| Interest Expense | 81 | 173 | 196 | 120 | 120 |
| Other Income | 719 | 733 | 482 | 310 | 330 |
| Pre-tax Income | -13,980 | -11,832 | -11,069 | -8,350 | -9,960 |
| Net Income Continuous | -13,980 | -11,832 | -11,069 | -7,951 | -9,900 |
| Net Income | $-13,980 | $-11,832 | $-11,069 | $-7,951 | $-9,900 |
| EPS Basic Total Ops | -6,598.68 | -5,878.82 | -6,958.61 | -10,437.91 | -7,678.46 |
| EPS Basic Continuous Ops | -6,592.12 | -5,799.95 | -6,831.40 | -6,116.15 | -7,615.38 |
| EPS Diluted Total Ops | -6,598.68 | -5,878.82 | -6,958.61 | -10,437.91 | -7,678.46 |
| EPS Diluted Continuous Ops | -6,592.12 | -5,799.95 | -6,831.40 | -6,116.15 | -7,615.38 |
| EBITDA(a) | $-11,951 | $-9,647 | $-8,552 | $-7,820 | $-9,650 |